IDEAYA Biosciences, Inc. Common Stock (IDYA)
PHARMACEUTICAL PREPARATIONS
IDEAYA Biosciences, Inc. Common Stock (IDYA) is listed on Nasdaq, where it has traded since May 23, 2019.
- Listed On
- Nasdaq
- Listed Since
- May 23, 2019
- Employees
- 145
- Market Cap
- $3.3B
About IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 276 institutions reported holding IDYA, with 102.0 million shares worth $3.8 billion in aggregate. The largest reported holder was FMR, with 14.1 million shares worth $525.9 million. Of the 5 largest holders listed below, all 5 added shares during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 14,109,431 | $526M | Added 7.12% |
| BlackRock | 8,893,260 | $331M | Added 5.34% |
| Janus Henderson (Jupiter Topco) | 8,579,881 | $320M | Added 18.09% |
| Vanguard | 5,713,460 | $213M | Added 10.61% |
| Capital Group | 5,344,701 | $199M | Added 3.51% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is IDYA?
IDEAYA Biosciences, Inc. Common Stock (IDYA) is listed on Nasdaq, where it has traded since May 23, 2019.
Who are the largest institutional holders of IDYA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IDYA were FMR, BlackRock and Janus Henderson (Jupiter Topco).
How many institutions own IDYA?
276 institutions reported a position in IDYA for the quarter ended June 30, 2026, worth $3.8 billion in total.
Did institutions buy or sell IDYA last quarter?
Of the 5 largest reported holders, all 5 added shares during the quarter. Every reported holder and its change is on the SentiSense ownership page for IDYA.
Every reported institutional holder, plus insider and congressional trades in IDYA, on SentiSense.